Literature DB >> 17404760

Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.

Aydin Ece1, Selvi Kelekçi, Aşkin Hekimoğlu, Halil Kocamaz, Hasan Balik, Ilyas Yolbaş, Ozcan Erel.   

Abstract

The aim of this study was to investigate the role of neutrophil activation, protein oxidation and ceruloplasmin (CLP) in the pathogenesis of Henoch-Schönlein purpura (HSP), which has not been investigated previously. Serum activities of myeloperoxidase (MPO) and arylesterase (ARYL) and levels of free thiol groups, CLP and total oxidant status (TOS) were measured in 29 children with HSP at the onset of the disease and during remission in comparison with 30 healthy subjects. Patients at active stage had significantly higher MPO activity (391+/-277 vs. 155+/-154 U/l, P<0.001), higher CLP (832+/-120 vs. 682+/-114 mg/dl, P<0.001) and TOS values (20.7+/-11.8 vs. 7.5+/-2.8 micromol H2O2/l, P<0.001) than the controls, respectively. Patients had significantly lower ARYL activity (158x10(3)+/-39x10(3) vs. 187x10(3)+/-46x10(3) U/l, P<0.001) and lower free thiol levels (234+/-48 vs. 279+/-26 micromol/l, P<0.001) than the controls, respectively. Significantly positive correlations were found between TOS and MPO (r=0.437, P=0.018) and TOS and CLP (r=0.409, P=0.028) at disease onset, whereas a negative correlation was found between MPO and thiol (r=-0.597, P=0.001) during remission. In conclusion, protein oxidation and neutrophil activation may play important roles in the pathogenesis of HSP. Further research is required to understand the potential linkage between oxidant stress and complications and to develop therapeutic strategies in HSP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404760     DOI: 10.1007/s00467-007-0475-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

Review 1.  Living with a killer: the effects of hypochlorous acid on mammalian cells.

Authors:  J M Pullar; M C Vissers; C C Winterbourn
Journal:  IUBMB Life       Date:  2000 Oct-Nov       Impact factor: 3.885

2.  Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Mehmet Davutoğlu; Meki Bilici; Murat Tutanç; Ali Güneş
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

Review 4.  Ceruloplasmin - acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease.

Authors:  Natalia Giurgea; Mihaela Ioana Constantinescu; Ramona Stanciu; Soimita Suciu; Adriana Muresan
Journal:  Med Sci Monit       Date:  2005-02

5.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

6.  Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.

Authors:  Philip E Morgan; Allan D Sturgess; Michael J Davies
Journal:  Arthritis Rheum       Date:  2005-07

7.  Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura.

Authors:  O Erdoğan; A Oner; A Aydin; A Işimer; G Demircin; M Bülbül
Journal:  Acta Paediatr       Date:  2003-05       Impact factor: 2.299

Review 8.  Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.

Authors:  Mike Mackness; Paul Durrington; Bharti Mackness
Journal:  Curr Opin Lipidol       Date:  2004-08       Impact factor: 4.776

9.  Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

Authors:  C Yazici; K Köse; M Caliş; M DemIr; M Kirnap; F Ateş
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

10.  Antioxidant protection against hypochlorous acid in human plasma.

Authors:  M L Hu; S Louie; C E Cross; P Motchnik; B Halliwell
Journal:  J Lab Clin Med       Date:  1993-02
View more
  4 in total

1.  Increased plasma myeloperoxidase levels in systemic lupus erythematosus.

Authors:  Rosa Weiss Telles; Gilda Aparecida Ferreira; Neusa Pereira da Silva; Emilia Inoue Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 2.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.

Authors:  Amjad A Khan; Mohammed A Alsahli; Arshad H Rahmani
Journal:  Med Sci (Basel)       Date:  2018-04-18

3.  Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.

Authors:  Yong-Rui Song; Wan-Liang Guo; Mao Sheng; Qiang Lin; Xue-Ming Zhu; Xiao-Zhong Li
Journal:  BMC Pediatr       Date:  2020-11-02       Impact factor: 2.125

Review 4.  A Review of the Mechanism of Vascular Endothelial Injury in Immunoglobulin A Vasculitis.

Authors:  Shanshan Xu; Shanshan Han; Yanlin Dai; Long Wang; Xia Zhang; Ying Ding
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.